With the Tear Film And Ocular Surface Society’s Dry Eye Workshop update comes a more nuanced definition of dry eye disease.

Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.

The US Food and Drug Administration has appointed George Francis Tidmarsh, MD, PhD, as director of the Center for Drug Evaluation and Research (CDER).

The FDA has accepted for review the second resubmitted NDA for reproxalap for the treatment of the signs and symptoms of dry eye disease.

Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin.

Cuts to Medicaid prompted by the One Big Beautiful Bill Act could lead to thousands of excess deaths each year.

Peripheral neuropathy (PN) risk factors seem to explain a higher prevalence of the disease among non-Hispanic Black individuals, but not among Hispanic individuals.

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke, and all-cause mortality compared with other ...